1059 related articles for article (PubMed ID: 27029350)
1. Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial.
Di Biase L; Mohanty P; Mohanty S; Santangeli P; Trivedi C; Lakkireddy D; Reddy M; Jais P; Themistoclakis S; Dello Russo A; Casella M; Pelargonio G; Narducci ML; Schweikert R; Neuzil P; Sanchez J; Horton R; Beheiry S; Hongo R; Hao S; Rossillo A; Forleo G; Tondo C; Burkhardt JD; Haissaguerre M; Natale A
Circulation; 2016 Apr; 133(17):1637-44. PubMed ID: 27029350
[TBL] [Abstract][Full Text] [Related]
2. Catheter Ablation Versus Best Medical Therapy in Patients With Persistent Atrial Fibrillation and Congestive Heart Failure: The Randomized AMICA Trial.
Kuck KH; Merkely B; Zahn R; Arentz T; Seidl K; Schlüter M; Tilz RR; Piorkowski C; Gellér L; Kleemann T; Hindricks G
Circ Arrhythm Electrophysiol; 2019 Dec; 12(12):e007731. PubMed ID: 31760819
[TBL] [Abstract][Full Text] [Related]
3. Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial).
Darkner S; Chen X; Hansen J; Pehrson S; Johannessen A; Nielsen JB; Svendsen JH
Eur Heart J; 2014 Dec; 35(47):3356-64. PubMed ID: 25182250
[TBL] [Abstract][Full Text] [Related]
4. Atrial Fibrillation in Heart Failure US Ambulatory Cardiology Practices and the Potential for Uptake of Catheter Ablation: An National Cardiovascular Data Registry (NCDR
Mathew JS; Marzec LN; Kennedy KF; Jones PG; Varosy PD; Masoudi FA; Maddox TM; Allen LA
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862932
[TBL] [Abstract][Full Text] [Related]
5. Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease).
Parkash R; Nault I; Rivard L; Gula L; Essebag V; Nery P; Tung S; Raymond JM; Sterns L; Doucette S; Wells G; Tang ASL; Stevenson WG; Sapp JL
Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e005663. PubMed ID: 29305400
[TBL] [Abstract][Full Text] [Related]
6. Randomized Study of Persistent Atrial Fibrillation Ablation: Ablate in Sinus Rhythm Versus Ablate Complex-Fractionated Atrial Electrograms in Atrial Fibrillation.
Bassiouny M; Saliba W; Hussein A; Rickard J; Diab M; Aman W; Dresing T; Callahan T; Bhargava M; Martin DO; Shao M; Baranowski B; Tarakji K; Tchou PJ; Hakim A; Kanj M; Lindsay B; Wazni O
Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003596. PubMed ID: 26857909
[TBL] [Abstract][Full Text] [Related]
7. Catheter ablation vs. amiodarone plus losartan for prevention of atrial fibrillation recurrence in patients with paroxysmal atrial fibrillation.
Lan X; Su L; Ling Z; Liu Z; Wu J; Yang X; Zrenner B; Yin Y
Eur J Clin Invest; 2009 Aug; 39(8):657-63. PubMed ID: 19490069
[TBL] [Abstract][Full Text] [Related]
8. Anxiety sensitivity moderates prognostic importance of rhythm-control versus rate-control strategies in patients with atrial fibrillation and congestive heart failure: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
Frasure-Smith N; Lespérance F; Talajic M; Khairy P; Dorian P; O'Meara E; Roy D
Circ Heart Fail; 2012 May; 5(3):322-30. PubMed ID: 22441774
[TBL] [Abstract][Full Text] [Related]
9. Selective complex fractionated atrial electrograms targeting for atrial fibrillation study (SELECT AF): a multicenter, randomized trial.
Verma A; Sanders P; Champagne J; Macle L; Nair GM; Calkins H; Wilber DJ
Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):55-62. PubMed ID: 24425420
[TBL] [Abstract][Full Text] [Related]
10. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Wilkoff BL; Cook JR; Epstein AE; Greene HL; Hallstrom AP; Hsia H; Kutalek SP; Sharma A;
JAMA; 2002 Dec; 288(24):3115-23. PubMed ID: 12495391
[TBL] [Abstract][Full Text] [Related]
11. Frequency and Outcomes of Postrandomization Atrial Tachyarrhythmias in the Resynchronization/Defibrillation in Ambulatory Heart Failure Trial.
Wilton SB; Exner DV; Wyse DG; Yetisir E; Wells G; Tang AS; Healey JS
Circ Arrhythm Electrophysiol; 2016 May; 9(5):. PubMed ID: 27162033
[TBL] [Abstract][Full Text] [Related]
12. Amiodarone after surgical ablation for atrial fibrillation: Is it really necessary? A prospective randomized controlled trial.
Ad N; Holmes SD; Shuman DJ; Pritchard G; Miller CE
J Thorac Cardiovasc Surg; 2016 Mar; 151(3):798-803. PubMed ID: 26253874
[TBL] [Abstract][Full Text] [Related]
13. Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success.
Schreiber D; Rostock T; Fröhlich M; Sultan A; Servatius H; Hoffmann BA; Lüker J; Berner I; Schäffer B; Wegscheider K; Lezius S; Willems S; Steven D
Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):308-17. PubMed ID: 25744570
[TBL] [Abstract][Full Text] [Related]
14. Progression of atrial fibrillation after a failed initial ablation procedure in patients with paroxysmal atrial fibrillation: a randomized comparison of drug therapy versus reablation.
Pokushalov E; Romanov A; De Melis M; Artyomenko S; Baranova V; Losik D; Bairamova S; Karaskov A; Mittal S; Steinberg JS
Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):754-60. PubMed ID: 23748210
[TBL] [Abstract][Full Text] [Related]
15. Natriuretic Propeptides as Markers of Atrial Fibrillation Burden and Recurrence (from the AMIO-CAT Trial).
Darkner S; Goetze JP; Chen X; Henningsen K; Pehrson S; Svendsen JH
Am J Cardiol; 2017 Oct; 120(8):1309-1315. PubMed ID: 28865890
[TBL] [Abstract][Full Text] [Related]
16. Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure.
Singh SN; Poole J; Anderson J; Hellkamp AS; Karasik P; Mark DB; Lee KL; Bardy GH;
Am Heart J; 2006 Nov; 152(5):974.e7-11. PubMed ID: 17070171
[TBL] [Abstract][Full Text] [Related]
17. Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control]).
Parkash R; Wells GA; Sapp JL; Healey JS; Tardif JC; Greiss I; Rivard L; Roux JF; Gula L; Nault I; Novak P; Birnie D; Ha A; Wilton SB; Mangat I; Gray C; Gardner M; Tang ASL
Circulation; 2017 May; 135(19):1788-1798. PubMed ID: 28228428
[TBL] [Abstract][Full Text] [Related]
18. Long-term clinical outcome of patients who failed catheter ablation of atrial fibrillation.
Bottoni N; Bertaglia E; Donateo P; Quartieri F; Iori M; Maggi R; Zoppo F; Brandolino G; Brignole M
Europace; 2015 Mar; 17(3):403-8. PubMed ID: 25336663
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial).
Hunter RJ; Berriman TJ; Diab I; Kamdar R; Richmond L; Baker V; Goromonzi F; Sawhney V; Duncan E; Page SP; Ullah W; Unsworth B; Mayet J; Dhinoja M; Earley MJ; Sporton S; Schilling RJ
Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):31-8. PubMed ID: 24382410
[TBL] [Abstract][Full Text] [Related]
20. Twelve-year follow-up of catheter ablation for atrial fibrillation: A prospective, multicenter, randomized study.
Bertaglia E; Senatore G; De Michieli L; De Simone A; Amellone C; Ferretto S; La Rocca V; Giuggia M; Corrado D; Zoppo F; Stabile G
Heart Rhythm; 2017 Apr; 14(4):486-492. PubMed ID: 27989681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
